Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Galbraith

Showing results (221-230 of 230) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 230 results.
Scandinavian Journal of Immunology|September 1, 1986
Inhibition of T3 mediated T-cell proliferation by Ca2+-channel blockers and inhibitors of Ca2+/phospholipid-dependent kinaseA E Nel, W Dirienzo, G F Stefanini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2003
Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imagingSusan M Galbraith, Ross J Maxwell, Martin A Lodge, et al.
American Heart Journal|March 12, 2011
Localization of culprit lesions in coronary arteries of patients with ST-segment elevation myocardial infarctions: relation to bifurcations and curvaturesMichael C McDaniel, Erin M Galbraith, Ahmad M Jeroudi, et al.
Cancer Research|December 25, 2002
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculaturePeter D Davis, Graeme J Dougherty, David C Blakey, et al.
Molecular Cancer Therapeutics|June 23, 2021
Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical DevelopmentSonja J Gill, Paul W G Wijnhoven, Jacqueline H L Fok, et al.
Acta Clinica Belgica|July 6, 2016
Selected SumariesD L Hart, J Dequeker, B M Iversen, et al.
Cancer Letters|September 4, 2017
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesionsTeresa Sadras, Susan L Heatley, Chung H Kok, et al.
The American Journal of Medicine|January 29, 1996
Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary diseaseD C Levin, K S Little, K R Laughlin, et al.
BMC Cancer|October 4, 2017
TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trialD Wittmann, A Mehta, L Northouse, et al.
Emerging Infectious Diseases|December 19, 2001
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United StatesJ A Jernigan, D S Stephens, D A Ashford, et al.
Pageof 23

Showing results (221-230 of 230) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
Scandinavian Journal of Immunology|September 1, 1986
Inhibition of T3 mediated T-cell proliferation by Ca2+-channel blockers and inhibitors of Ca2+/phospholipid-dependent kinaseA E Nel, W Dirienzo, G F Stefanini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2003
Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imagingSusan M Galbraith, Ross J Maxwell, Martin A Lodge, et al.
American Heart Journal|March 12, 2011
Localization of culprit lesions in coronary arteries of patients with ST-segment elevation myocardial infarctions: relation to bifurcations and curvaturesMichael C McDaniel, Erin M Galbraith, Ahmad M Jeroudi, et al.
Cancer Research|December 25, 2002
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculaturePeter D Davis, Graeme J Dougherty, David C Blakey, et al.
Molecular Cancer Therapeutics|June 23, 2021
Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical DevelopmentSonja J Gill, Paul W G Wijnhoven, Jacqueline H L Fok, et al.
Acta Clinica Belgica|July 6, 2016
Selected SumariesD L Hart, J Dequeker, B M Iversen, et al.
Cancer Letters|September 4, 2017
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesionsTeresa Sadras, Susan L Heatley, Chung H Kok, et al.
The American Journal of Medicine|January 29, 1996
Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary diseaseD C Levin, K S Little, K R Laughlin, et al.
BMC Cancer|October 4, 2017
TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trialD Wittmann, A Mehta, L Northouse, et al.
Emerging Infectious Diseases|December 19, 2001
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United StatesJ A Jernigan, D S Stephens, D A Ashford, et al.
Pageof 23